Although in general the ki67 index is being recognized as a powerful determinant of survival in patients with GEP NETs and it is known as a major prognostic factor for NETs [56, 57, 65], its relevance in metastatic disease and potential cutoff values for the different treatment modalities are still undefined because of a lack of data. This evidence concerns the gene MKI67 and metastatic neoplasm.